nbUVB

DEVICE5 trials

Sponsors

University of Texas Southwestern Medical Center, Innovaderm Research Inc., Joint Authority for Päijät-Häme Social and Health Care, Cairo University

Conditions

Fungal ResistancePityriasis LichenoidesPsoriasis VulgarisVitamin D DeficiencyVitiligo

Phase 4

Safety and Efficacy of Combining nbUVB to Etanercept in Patients

CompletedNCT00640393

Innovaderm Research Inc.Psoriasis Vulgaris

Start: 2008-04-30End: 2010-03-31Updated: 2011-09-09

Unknown Phase

The Efficacy of Hand Narrow-Band Ultraviolet B (NBUVB) Versus Excilite Treatment in Vitiligo After Minigrafting on the Dorsal Hands

CompletedNCT00622180

University of Texas Southwestern Medical CenterVitiligo

Start: 2008-01-31End: 2009-03-31Updated: 2019-11-05

The Role of Narrowband Ultraviolet B Exposure in the Maintenance of Vitamin D Levels During Winter

CompletedNCT02275650

Joint Authority for Päijät-Häme Social and Health CareVitamin D Deficiency

Start: 2013-09-30End: 2014-05-31Updated: 2014-10-27

Pityriasis Lichenoides Chronica, Role of Streptococcal Infection and Azithromycin

Cairo UniversityPityriasis Lichenoides

Start: 2019-02-28End: 2020-08-31Target: 30Updated: 2019-02-05

Efficacy of Ultraviolet B Phototherapy in the Management of Resistant and Relapsing Tinea Corporis and Tinea Cruris

Not yet recruitingNCT07242703

Cairo UniversityFungal Resistance

Start: 2025-12-01End: 2026-05-01Target: 36Updated: 2025-11-21

Related Papers

Role of streptococcal infection in the etiopathogenesis of pityriasis lichenoides chronica and the therapeutic efficacy of azithromycin: a randomized controlled trial.

2022-09-211 citations

A randomized study comparing the combination of nbUVB and etanercept to etanercept monotherapy in patients with psoriasis who do not exhibit an excellent response after 12 weeks of etanercept.

2011-08-1027 citations